Literature DB >> 12120781

Polyadenylate polymerase (PAP) and 3' end pre-mRNA processing: function, assays, and association with disease.

Andreas Scorilas1.   

Abstract

Polyadenylate polymerase (PAP) is one of the enzymes involved in the formation of the polyadenylate tail of the 3' end of mRNA. Poly (A) tail formation is a significant component of 3' processing, a link in the chain of events, including transcription, splicing, and cleavage/polyadenylation of pre-mRNA. Transcription, capping, splicing, polyadenylation, and transport take place as coupled processes that can regulate one another. The poly(A) tail is found in almost all eukaryotic mRNA and is important in enhancing translation initiation and determining mRNA stability. Control of poly(A) tail synthesis could possibly be a key regulatory step in gene expression. PAP-specific activity values are measured by a highly sensitive assays and immunocytochemical methods. High levels of PAP activity are associated with rapidly proliferating cells, it also prevents apoptosis. Changes of PAP activity may cause a decrease in the rate of polyadenylation in the brain during epileptic seizures. Testis-specific PAP may play an important role in spermiogenesis. PAP was found to be an unfavorable prognostic factor in leukemia and breast cancer. Furthermore, measurements of PAP activity may contribute to the definition of the biological profile of tumor cells. It is crucial to know the specific target causing the elevation of serum PAP, for it to be used as a marker for disease. This review summarizes the recently accumulated knowledge on PAP including its function, assays, and association with various human diseases, and proposes future avenues for research.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12120781     DOI: 10.1080/10408360290795510

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  15 in total

1.  BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II.

Authors:  Frida E Kleiman; Foon Wu-Baer; Danae Fonseca; Syuzo Kaneko; Richard Baer; James L Manley
Journal:  Genes Dev       Date:  2005-05-15       Impact factor: 11.361

Review 2.  3' end mRNA processing: molecular mechanisms and implications for health and disease.

Authors:  Sven Danckwardt; Matthias W Hentze; Andreas E Kulozik
Journal:  EMBO J       Date:  2008-02-06       Impact factor: 11.598

Review 3.  RNA surveillance: molecular approaches in transcript quality control and their implications in clinical diseases.

Authors:  Karen C M Moraes
Journal:  Mol Med       Date:  2009-10-07       Impact factor: 6.354

Review 4.  Implications of polyadenylation in health and disease.

Authors:  Ana Curinha; Sandra Oliveira Braz; Isabel Pereira-Castro; Andrea Cruz; Alexandra Moreira
Journal:  Nucleus       Date:  2014-10-31       Impact factor: 4.197

Review 5.  Principles of miRNA-mRNA interactions: beyond sequence complementarity.

Authors:  Fabian Afonso-Grunz; Sören Müller
Journal:  Cell Mol Life Sci       Date:  2015-06-03       Impact factor: 9.261

6.  The RNA helicase Mtr4p modulates polyadenylation in the TRAMP complex.

Authors:  Huijue Jia; Xuying Wang; Fei Liu; Ulf-Peter Guenther; Sukanya Srinivasan; James T Anderson; Eckhard Jankowsky
Journal:  Cell       Date:  2011-06-10       Impact factor: 41.582

7.  Nuclear deadenylation/polyadenylation factors regulate 3' processing in response to DNA damage.

Authors:  Murat A Cevher; Xiaokan Zhang; Sully Fernandez; Sergey Kim; Jorge Baquero; Per Nilsson; Sean Lee; Anders Virtanen; Frida E Kleiman
Journal:  EMBO J       Date:  2010-04-08       Impact factor: 11.598

8.  Star-PAP controlled alternative polyadenylation coupled poly(A) tail length regulates protein expression in hypertrophic heart.

Authors:  A P Sudheesh; Nimmy Mohan; Nimmy Francis; Rakesh S Laishram; Richard A Anderson
Journal:  Nucleic Acids Res       Date:  2019-11-18       Impact factor: 16.971

9.  Sumoylation regulates multiple aspects of mammalian poly(A) polymerase function.

Authors:  Vasupradha Vethantham; Nishta Rao; James L Manley
Journal:  Genes Dev       Date:  2008-02-15       Impact factor: 11.361

10.  Molecular beacons can assess changes in expression and 3'-polyadenylation of human eNOS mRNA.

Authors:  Rachel Jones; Meredith B Baker; Martina Weber; David G Harrison; Gang Bao; Charles D Searles
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-24       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.